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Abstract
Background
Cigarette smoking is associated with earlier menopause, but the impact of being a former
smoker and any dose-response relationships on the degree of smoking and age at
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menopause have been less clear. If the toxic impact of cigarette smoking on ovarian func-
tion is irreversible, we hypothesized that even former smokers might experience earlier
menopause, and variations in intensity, duration, cumulative dose, and age at start/quit of
smoking might have varying impacts on the risk of experiencing earlier menopause.
Methods and findings
A total of 207,231 and 27,580 postmenopausal women were included in the cross-sectional
and prospective analyses, respectively. They were from 17 studies in 7 countries (Australia,
Denmark, France, Japan, Sweden, United Kingdom, United States) that contributed data to
the International collaboration for a Life course Approach to reproductive health and Chronic
disease Events (InterLACE). Information on smoking status, cigarettes smoked per day
(intensity), smoking duration, pack-years (cumulative dose), age started, and years since
quitting smoking was collected at baseline. We used multinomial logistic regression models
to estimate multivariable relative risk ratios (RRRs) and 95% confidence intervals (CIs) for
the associations between each smoking measure and categorised age at menopause (<40
(premature), 40–44 (early), 45–49, 50–51 (reference), and�52 years). The association with
current and former smokers was analysed separately. Sensitivity analyses and two-step
meta-analyses were also conducted to test the results. The Bayesian information criterion
(BIC) was used to compare the fit of the models of smoking measures.
Overall, 1.9% and 7.3% of women experienced premature and early menopause,
respectively. Compared with never smokers, current smokers had around twice the risk of
experiencing premature (RRR 2.05; 95% CI 1.73–2.44) (p < 0.001) and early menopause
(1.80; 1.66–1.95) (p < 0.001). The corresponding RRRs in former smokers were attenuated
to 1.13 (1.04–1.23; p = 0.006) and 1.15 (1.05–1.27; p = 0.005). In both current and former
smokers, dose-response relationships were observed, i.e., higher intensity, longer duration,
higher cumulative dose, earlier age at start smoking, and shorter time since quitting smoking
were significantly associated with higher risk of premature and early menopause, as well as
earlier menopause at 45–49 years. Duration of smoking was a strong predictor of age at nat-
ural menopause. Among current smokers with duration of 15–20 years, the risk was
markedly higher for premature (15.58; 11.29–19.86; p < 0.001) and early (6.55; 5.04–8.52;
p < 0.001) menopause. Also, current smokers with 11–15 pack-years had over 4-fold (4.35;
2.78–5.92; p < 0.001) and 3-fold (3.01; 2.15–4.21; p < 0.001) risk of premature and early
menopause, respectively. Smokers who had quit smoking for more than 10 years had simi-
lar risk as never smokers (1.04; 0.98–1.10; p = 0.176). A limitation of the study is the mea-
surement errors that may have arisen due to recall bias.
Conclusions
The probability of earlier menopause is positively associated with intensity, duration, cumu-
lative dose, and earlier initiation of smoking. Smoking duration is a much stronger predictor
of premature and early menopause than others. Our findings highlight the clear benefits for
women of early smoking cessation to lower their excess risk of earlier menopause.
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Author summary
Why was this study done?
• Current smoking is associated with earlier age at natural menopause.
• The impact of former smoking on age at natural menopause is inconclusive, and the
dose-response relationships between the degree of smoking (including intensity and
duration) and age at natural menopause have been less clear.
What did the researchers do and find?
• We pooled individual-level data from 17 observational studies that contributed to the
International collaboration for a Life course Approach to reproductive health and
Chronic disease Events (InterLACE) consortium. A total of 207,231 and 27,580 post-
menopausal women were included in the cross-sectional and prospective analyses,
respectively.
• We examined the associations between smoking measures (smoking status, intensity,
duration, cumulative dose, and timing of cigarette smoking) and age at natural
menopause.
• Compared with never smokers, former smokers had around 15% higher risk of prema-
ture and early menopause, but this was much lower than that of current smokers, who
had double the risk when compared to never smokers.
• Early menopause is positively associated with intensity, duration, cumulative dose, and
earlier initiation of smoking in both current and former smokers. Duration of smoking
was a strong predictor of early menopause.
What do these findings mean?
• Our findings highlight the clear benefits for women of early smoking cessation to lower
their excess risk of earlier menopause, thereby reducing the increased risks of chronic
diseases (e.g., cardiovascular disease and osteoporosis) associated with both smoking
and earlier menopause.
Introduction
Natural menopause is defined as when a woman has had no menstrual periods for 12 consecu-
tive months that did not result from interventions (such as bilateral oophorectomy, hysterec-
tomy, chemotherapy, or radiotherapy). It typically occurs between 49 and 52 years of age, with
a median age of 51.4 years in high-income countries [1–3]. Approximately 5% of women
report early menopause [4,5], occurring between ages 40 and 45 years, whereas premature
menopause—also termed premature ovarian failure (POF)—occurs before age 40 years [5] in
about 1% of women [6,7]. Women with early or premature menopause are at increased risk of
morbidity and mortality in later life, including cardiovascular disease [8,9], osteoporosis [9],
and type 2 diabetes [10,11].
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In addition to genetic factors [5], socioeconomic status, body weight, cigarette smoking,
race/ethnicity, age at menarche, and nulliparity influence age at menopause [12–15]. Cigarette
smoking is the most established factor and leads to having menopause by almost one year ear-
lier [3,15,16], but important knowledge gaps remain. A recent systematic review of 109 studies
concluded that although current smoking is associated with earlier age at menopause, evidence
for the impact of being a former smoker was inconclusive. In addition, dose-response relation-
ships on the degree of smoking and age at menopause have been less clear [16], and few studies
have examined the relationship between age at start [17,18] or quit of smoking [19,20] and age
at menopause. If the hypothesized toxic impact of cigarette smoking on ovarian function is
irreversible [21], even former smokers may experience earlier menopause, and variations in
intensity, duration, cumulative dose, as well as age at start/quit of smoking might have varying
impacts on the risk of experiencing earlier menopause.
To investigate these issues, we analysed individual-level data from more than 200,000 post-
menopausal women in 17 studies that contributed data to the International collaboration for a
Life course Approach to reproductive health and Chronic disease Events (InterLACE) [22,23].
Dose-response relationships were investigated between the multiple aspects of smoking and
age at menopause in both cross-sectional and prospective analyses.
Methods
Participants
InterLACE has pooled individual-level data on reproductive health and chronic diseases from
over 500,000 women from 25 observational studies across 10 countries. Most studies are pro-
spective and collected survey data on key reproductive, sociodemographic, and lifestyle factors,
as well as disease outcomes. Participants in each of the included studies were recruited and
provided consent according to the approved protocols of the Institutional Review Board or
Human Research Ethics Committee at each relevant institution. More detailed descriptions of
the InterLACE consortium have been published previously [22,23]. For the present analyses,
17 studies of InterLACE (Table 1) provided information on women’s smoking status at the
baseline survey and age at natural menopause. Of these, 14 collected longitudinal data, while
the remaining 3 provided only cross-sectional information. As the use of hormone therapy
(HT) and oral contraceptive pills (OCPs) precludes accurate definition of menopausal status,
hormone users were excluded from the analyses unless natural menopause was specifically
reported. The cross-sectional analysis was based on 207,231 postmenopausal women with
information on age at natural menopause (i.e., women who experienced surgical menopause
were excluded), smoking status, and key covariates at baseline, BMI, years of education, and
race/ethnicity/region. The prospective analysis was based on 27,580 women who experienced
menopause after the baseline survey. This study is reported as per the Strengthening the
Reporting of Observational Studies in Epidemiology (STROBE) guidelines (S1 Text).
Outcome and exposure variables
Age at natural menopause was the outcome variable and was self-reported. In the cross-sec-
tional analyses, age at menopause was categorised as<40 years (premature menopause), 40–
44 (early menopause), 45–49, 50–51 (reference category), and 52 years and above, while in the
prospective analyses—due to the insufficient number of women with premature menopause—
age at menopause was classified into 4 categories by combining the premature and early meno-
pause groups as<45 years.
Information on smoking status, intensity, duration, and timing of cigarette smoking was
collected through self-reported questionnaires. Smoking status was categorised as current,
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PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002704 November 27, 2018 4 / 19
former, or never. Current smokers were defined as women who started smoking before meno-
pause and were regular smokers at baseline or who experienced menopause before they quit
smoking. Former smokers were defined as women who experienced menopause after they quit
smoking at least 1 year. Smoking intensity was defined as the average number of cigarettes
smoked per day categorised as 1–9, 10–19, and 20 cigarettes or more. Among former smokers,
duration was defined as the difference between the reported age at starting and quitting and,
for current smokers, the difference between the age at starting and age at menopause. There-
fore, by definition of duration in current smokers, women with later menopause would tend
to have a longer duration. In order to observe the association between smoking duration and
earlier menopause, we focused on short duration of smoking (similar reason for categories of
pack-years and years since quitting smoking). To determine appropriate categories for dura-
tion of smoking, we used a fractional-polynomial model to plot the shape of the relationship
between smoking duration (in all current smokers) and age at menopause. As expected, we
found a U-shape, and duration of 20 years was determined as an appropriate cut-point to
Table 1. Characteristics of individual studies in the InterLACE consortium for cross-sectional analysis�.
Study Country N Age in years at baseline Age in years at last follow-
up
Women’s year of birth (%)
Mean
(SD)
Median (Q1,
Q3)
Mean (SD) <1930 1930–
1939
1940–
1949
1950+
ALSWH Australia 7,353 47.6 (1.4) 47.6 (46.4, 48.9) 63.1 (3.4) - - 75 25
HOW Australia 338 54.8 (2.7) 55.0 (53.0, 57.0) 62.5 (4.0) - - 87.9 12.1
MCCS Australia 12,876 58.7 (7.2) 59.5 (53.6, 64.6) 67.9 (7.6) 35.6 42.6 19.8 2
DNC Denmark 8,868 59.6 (7.8) 58.0 (54.0, 64.0) 69.8 (8.8) 29.2 51.3 19.4 -
French 3C France 4,253 74.5 (5.7) 73.9 (69.9, 78.3) 74.5 (5.7) 72.2 27.8 - -
JNHS Japan 5,331 54.7 (4.0) 55.0 (52.0, 57.0) 54.7 (4.0) - 1.6 63.9 34.5
WLH Sweden 11,071 45.0 (3.6) 46.0 (43.0, 48.0) 55.8 (3.8) - - 77 23
MRC NSHD† UK 732 47.0 47.0 53.8 - - 100 -
NCDS† UK 2,542 50.0 50.0 54.8 - - - 100
ELSA UK 2,967 60.4 (10.0) 59.0 (52.0, 68.0) 70.8 (9.6) 21.2 28.5 37.3 13.1
UKWCS UK 8,465 58.1 (7.3) 58.0 (52.8, 63.5) 60.9 (7.3) 13.5 42.4 39 5.1
WHITEHALL UK 1,647 46.5 (5.9) 47.0 (41.0, 52.0) 64.1 (6.4) - 49.9 43.8 6.2
SABRE UK 453 56.5 (5.0) 57.0 (53.0, 60.0) 63.4 (9.8) 19.9 67.1 13 -
UK Biobank UK 138,014 59.7 (5.6) 60.0 (56.0, 64.0) 59.7 (5.6) - 4.1 55.8 40.1
HILO USA 306 55.8 (4.8) 55.6 (52.8, 59.4) 55.8 (4.8) - - 52.9 46.7
SWAN USA 1,907 46.5 (2.6) 46.0 (44.0, 48.0) 56.0 (2.9) - - 49.1 50.9
Seattle Middle Women’s Health Study
(SMWHS
USA 108 42.0 (4.4) 41.9 (38.3, 45.0) 49.9 (3.8) - 2.8 52.8 44.4
All 207,231 58.0 (7.7) 59.0 (53.0, 63.9) 60.9 (7.1) 5.8 10.9 51.2 32.1
�In the cross-sectional analysis, women who had complete information on age at menopause, smoking status, BMI, education level, and race/ethnicity/region at baseline
were included.
†NSHD (1946 British Birth Cohort) and NCDS (1958 British Birth Cohort) first collected information on women’s health in 1993 (aged 47) and 2008 (aged 50),
respectively, so we used age 47 and age 50 as the baseline age for the current study.
Abbreviations: ALSWH, Australian Longitudinal Study on Women’s Health; DNC, Danish Nurse Cohort Study; ELSA, English Longitudinal Study of Ageing; French
3C, French Three-City Study; HILO, Hilo Women’s Healthy Study; HOW, Healthy Ageing of Women Study; InterLACE, International Collaboration for a Life Course
Approach to Reproductive Health and Chronic Disease Events; JNHS, Japan Nurses’ Health Study; MCCS, Melbourne Collaborative Cohort Study; MRC, Medical
Research Council; NSHD, National Survey of Health and Development; NCDS, National Child Development Study; Q1, the first quartile; Q3, the third quartile; SABRE,
Southall And Brent Revisited; SMWHS, Seattle Middle Women’s Health Study; SWAN, Study of Women’s Health Across the Nation; UKWCS, UK Women’s Cohort
Study; WHITEHALL, Whitehall II study; WLH, Women’s Lifestyle and Health Study.
https://doi.org/10.1371/journal.pmed.1002704.t001
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define a maximum duration that had an impact on age at menopause. Duration of smoking
was then categorised as<10, 10–14, and 15–20 years. The cumulative dose of smoking was cal-
culated as pack-years (the number of cigarettes smoked per day divided by 20 [assuming 20
cigarettes a pack] and multiplied by the duration of smoking) [17]. We categorized pack-years
as�5, 6–10, and 11–15. Other smoking characteristics included age when a woman started
smoking (categorised as<15, 15–19, 20 or more years of age), and years since quitting smok-
ing (calculated by taking the difference between age at menopause and age at quitting). Inher-
ent in the definition of years since quitting smoking, age at menopause places an upper time
limit possible. Thus, in the analysis we focused on the more recent years since quitting (catego-
rised as 1–5, 6–10, and 11–15 years).
Covariates
Baseline BMI, years of education, race/ethnicity/region, parity, and age at menarche were used
as covariates because these have been shown to be associated with age at menopause [14,15].
BMI was categorised according to World Health Organization (WHO) criteria as<18.5 kg/
m2, 18.5 to 24.9 kg/m2, 25 to 29.9 kg/m2, and�30 kg/m2. Years of education was categorised
into�10, 11–12, and >12 years. Race/ethnicity/region was combined into one, with 7 catego-
ries: White European, White Australian/New Zealand, White American/Canadian, Japanese,
Other Asian, African American/Black, and Other. Parity was categorised as none, one child,
two children, and three or more children. Age at menarche was divided into 5 categories as
�11, 12, 13, 14, and 15 years or more.
Statistical analyses
The data analyses for the present study were performed following a prospective research pro-
posal (S2 Text). We performed pooled analyses of all the individual-level data. Multinomial
(polytomous) logistic regression models with 5 categories of outcome for age at menopause
(<40, 40–44, 45–49, 50–51, and 52 years and older) were used, with age 50–51 years at meno-
pause as a reference group. The intensity, duration, cumulative dose, and age started smoking
were analysed in combination with smoking status for current and former smokers. Never
smokers were used as reference for all smoking measures. All statistical models were adjusted
for BMI, education level, a combined variable for race/ethnicity/region, based on the estab-
lished relations of these in the literature to the outcome. Age at menarche and parity were also
potential confounders that could affect the association between smoking exposures and age at
menopause. Thus, the models were additionally adjusted for both covariates but with only 14
studies included because the WHITEHALL and Southall And Brent Revisited (SABRE) studies
did not collect age at menarche and Healthy Ageing of Women (HOW) study did not collect
parity. Adjusted RRRs (i.e., the ratio of two relative risks, RRRs) [24] and 95% confidence
intervals (CIs) for smoking measures and each category of age at menopause were estimated.
The Bayesian information criterion (BIC) was used to compare the fit of the models that used
each of the measures of smoking characteristic. A lower BIC implies a better fit.
Sensitivity analyses and two-step meta-analyses. Because the UK Biobank data contrib-
uted more than 60% of the total sample used in the cross-sectional analyses, we conducted a
sensitivity analysis by excluding this study. Also, we analysed the associations of intensity,
duration, age of starting smoking, and years since quitting with age at menopause by adjusting
for all covariates, including the other smoking characteristics. Finally, in order to evaluate the
heterogeneity among studies, in both cross-sectional and prospective analyses, we also per-
formed study-specific regressions and random-effects meta-analysis for the associations
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between each level of the cigarette smoking measures and each category of menopausal age to
estimate the magnitude of association.
Statistical analyses were performed by using SAS (version 9.4; SAS Institute Inc., Cary, NC)
and Stata (version 14.0; Stata Corp., College Station, TX). In SAS, the SURVEYLOGISTIC pro-
cedure was used with the generalized logit link to adjust for the clustering of data within stud-
ies to obtain robust standard errors. The SGPANEL procedure was used to plot the
associations. In STATA, the METAN command was used to perform meta-analysis. All statis-
tical tests were based on the two-sided 5% level of significance.
Results
Baseline characteristics
The mean age at baseline was 58.0 years (range 42.0 to 74.5 years), with more than half of the
women born between 1940 and 1949 (Table 1). Most women were white European (85.8%).
The mean age at natural menopause was 50.2 years (SD: 4.4), and the median was 50.0 years
(interquartile range: 48.0–53.0), with 57.5% of participants being never smokers, 30.7% for-
mer, and 11.8% current smokers at baseline. Current smokers had a longer duration of smok-
ing (mean: 29.6 versus 19.4 years) and higher number of pack-years (mean: 22.9 versus 16.7
pack-years) than former smokers (Table 2).
Table 2. Overall baseline characteristics of women used for cross-sectional analysis (n = 207,231).
Characteristics n (%) or mean ± SD
Race/ethnicity/region
White (Australia) 14,594 (7.0)
White (Europe) 177,810 (85.8)
White (USA) 1,187 (0.6)
Japanese 5,644 (2.7)
Other Asian 2,918 (1.4)
African American/Black 2,489 (1.2)
Other 2,589 (1.3)
Education level
�10 years 99,615 (48.1)
11–12 years 24,292 (11.7)
>12 years 83,324 (40.2)
BMI (kg/m2)
Underweight, <18.5 4,303 (2.1)
Normal, 18.5–24.9 91,690 (44.3)
Overweight, 25.0–29.9 71,352 (34.4)
Obese,�30 39,886 (19.3)
Age at menarche
�11 years 35,434 (18.1)
12 years 37,801 (19.3)
13 years 49,466 (25.2)
14 years 40,329 (20.6)
�15 years 33,017 (16.8)
Number of children
0 33,125 (16.2)
1 25,815 (12.6)
2 87,659 (42.9)
(Continued)
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Cross-sectional associations
Compared with never smokers, current smokers experienced an increased risk of premature
(RRR 2.05, 95% CI 1.73–2.44; p< 0.001) and early (1.80; 1.66–1.95; p< 0.001) menopause as
well as earlier menopause at 45–49 years (1.47; 1.42–1.52; p< 0.001). In former smokers, the
corresponding RRRs were substantially attenuated to 1.13 (1.04–1.23; p = 0.006), 1.15 (1.05–
1.27; p = 0.005), and 1.09 (1.05–1.13; p< 0.001), respectively (Table 3). A consistent trend was
found between all measures of smoking characteristics and age at menopause. Current smok-
ers with long duration of smoking had much higher risk of premature menopause and early
menopause, with RRR of 15.58 (95% CI 11.29–19.86; p< 0.001) and 6.55 (95% CI 5.04–8.52;
p< 0.001), respectively, in duration 15–20 years. In both current and former smokers, dose-
response relationships were observed in all measures of smoking characteristics, i.e., higher
intensity, longer duration, higher cumulative dose, earlier age at start smoking, and shorter
time since quitting smoking were significantly associated with higher risk of premature and
early menopause, as well as earlier menopause at 45–49 years (Table 3, Fig 1). Compared with
never smokers, women who had recently quit smoking (within 5 years) had an increased risk
of premature (1.70; 1.56–1.86; p< 0.001) and early (1.70; 1.49–1.93; p< 0.001) menopause,
which were close to the levels of risk seen in current smokers (Table 3). Duration of smoking
had the lowest BIC value (366,427), followed by cumulative dose (381,329). When further
Table 2. (Continued)
Characteristics n (%) or mean ± SD
�3 57,922 (28.3)
Age at natural menopause, mean ± SD 50.2 ± 4.4
Age at natural menopause
<40 years 3,895 (1.9)
40–44 years 15,134 (7.3)
45–49 years 51,706 (25.0)
50–51 years 50,736 (24.5)
�52 years 85,760 (41.4)
Smoking status
Never smoker 119,072 (57.5)
Former smoker 63,715 (30.7)
Current smoker 24,444 (11.8)
Intensity of smoking (cigarettes/day) (n = 58,843)�
Former smokers, mean ± SD 16.0 ± 9.1
Current smokers, mean ± SD 14.6 ± 8.4
Duration of smoking (years) (n = 59,290)�
Former smokers, mean ± SD 19.4 ± 10.1
Current smokers, mean ± SD 29.6 ± 7.0
Cumulative dose of smoking (pack-years) (n = 57,772)�
Former smokers, mean ± SD 16.7 ± 13.0
Current smokers, mean ± SD 22.9 ± 13.7
Age started smoking (years) (n = 63,695)�
Former smokers, mean ± SD 18.4 ± 4.4
Current smokers, mean ± SD 19.5 ± 6.6
Years since quitting smoking (n = 39,823),� mean ± SD 16.3 ± 9.1
�The numbers were based on the available number of women who reported that information.
https://doi.org/10.1371/journal.pmed.1002704.t002
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Table 3. Cross-sectional associations between cigarette smoking and age at menopause (n = 207,231).
N Age in years at menopause, n (%) Adjusted RRR (95% CI)�
<40 40–44 45–49 50–51 �52 <40 40–44 45–49 �52
Smoking status
Never smoker 119,072 1,965
(1.7)
7,776
(6.5)
27,950
(23.5)
29,674
(24.9)
51,707
(43.4)
1.00 1.00 1.00 1.00
Former smoker 63,715 1,161
(1.8)
4,705
(7.4)
15,656
(24.6)
15,391
(24.2)
26,802
(42.1)
1.13 (1.04–
1.23)
1.15 (1.05–
1.27)
1.09 (1.05–
1.13)
0.98 (0.95–
1.00)
Current smoker 24,444 769
(3.1)
2,653
(10.9)
8,100
(33.1)
5,671
(23.2)
7,251
(29.7)
2.05 (1.73–
2.44)
1.80 (1.66–
1.95)
1.47 (1.42–
1.52)
0.75 (0.72–
0.79)
Intensity of smoking, cigarettes/day
Never smoker 119,072 1,965
(1.7)
7,776
(6.5)
27,950
(23.5)
29,674
(24.9)
51,707
(43.4)
1.00 1.00 1.00 1.00
Former smokers + 1–9 cigs/day 7,933 116
(1.5)
495 (6.2) 1,932
(24.4)
1,957
(24.7)
3,433
(43.3)
0.93 (0.75–
1.16)
0.99 (0.78–
1.24)
1.02 (0.96–
1.08)
1.02 (0.97–
1.07)
Former smokers + 10–19 cigs/day 14,892 276
(1.9)
1,148
(7.7)
3,796
(25.5)
3,525
(23.7)
6,147
(41.3)
1.18 (1.03–
1.35)
1.23 (1.12–
1.35)
1.16 (1.12–
1.21)
0.97 (0.91–
1.04)
Former smokers + 20 or more cigs/
day
16,884 392
(2.3)
1,522
(9.0)
4,342
(25.7)
4,013
(23.8)
6,615
(39.2)
1.41 (1.30–
1.53)
1.40 (1.28–
1.53)
1.17 (1.12–
1.23)
0.90 (0.87–
0.93)
Current smokers + 1–9 cigs/day 4,594 113
(2.5)
399 (8.7) 1,435
(31.2)
1,092
(23.8)
1,555
(33.8)
1.59 (1.27–
1.98)
1.40 (1.17–
1.68)
1.34 (1.27–
1.42)
0.84 (0.80–
0.89)
Current smokers + 10–19 cigs/day 8,335 285
(3.4)
989
(11.9)
2,823
(33.9)
1,918
(23.0)
2,320
(27.8)
2.23 (1.68–
2.95)
1.95 (1.65–
2.32)
1.51 (1.41–
1.62)
0.71 (0.67–
0.76)
Current smokers + 20 or more cigs/
day
6,205 255
(4.1)
799
(12.9)
2,173
(35.0)
1,367
(22.0)
1,611
(26.0)
2.71 (2.23–
3.29)
2.19 (2.00–
2.40)
1.64 (1.51–
1.80)
0.68 (0.63–
0.74)
Duration of smoking before
menopause, years
Never smoker 119,072 1,965
(1.7)
7,776
(6.5)
27,950
(23.5)
29,674
(24.9)
51,707
(43.4)
1.00 1.00 1.00 1.00
Former smokers + duration <10 9,064 150
(1.7)
551 (6.1) 2,175
(24.0)
2,257
(24.9)
3,931
(43.4)
1.00 (0.77–
1.29)
0.94 (0.88–
1.01)
0.99 (0.91–
1.08)
1.03 (0.97–
1.08)
Former smokers + duration 10–14 6,551 149
(2.3)
453 (6.9) 1,551
(23.7)
1,637
(25.0)
2,761
(42.1)
1.35 (0.95–
1.92)
1.05 (0.88–
1.26)
1.00 (0.95–
1.05)
0.96 (0.93–
1.00)
Former smokers + duration 15–20 5,798 199
(3.4)
506 (8.7) 1,394
(24.0)
1,337
(23.1)
2,362
(40.7)
2.25 (1.50–
3.37)
1.44 (1.18–
1.75)
1.12 (1.05–
1.18)
0.99 (0.93–
1.05)
Current smokers + duration <10 295 27 (9.2) 42 (14.2) 114 (38.6) 48 (16.3) 64 (21.7) 9.22 (5.56–
15.28)
3.48 (2.04–
5.94)
2.26 (2.06–
2.47)
0.76 (0.37–
1.59)
Current smokers + duration 10–14 596 109
(18.3)
115
(19.3)
177 (29.7) 100 (16.8) 95 (15.9) 14.34 (10.37–
18.49)
4.53 (2.91–
7.05)
1.90 (1.58–
2.28)
0.55 (0.46–
0.65)
Current smokers + duration 15–20 1,138 223
(19.6)
276
(24.3)
359 (31.5) 170 (14.9) 110 (9.7) 15.58 (11.29–
19.86)
6.55 (5.04–
8.52)
2.58 (1.98–
3.36)
0.38 (0.28–
0.50)
Cumulative dose of smoking, pack-
years
Never smoker 119,072 1,965
(1.7)
7,776
(6.5)
27,950
(23.5)
29,674
(24.9)
51,707
(43.4)
1.00 1.00 1.00 1.00
Former smokers + pack-years�5 7,310 104
(1.4)
443 (6.1) 1,697
(23.2)
1,794
(24.5)
3,272
(44.8)
0.96 (0.73–
1.24)
0.98 (0.81–
1.19)
1.02 (0.95–
1.10)
1.04 (0.97–
1.11)
Former smokers + pack-years 6–10 6,288 128
(2.0)
420 (6.7) 1,456
(23.2)
1,534
(24.4)
2,750
(43.7)
1.29 (0.97–
1.70)
1.05 (0.93–
1.17)
1.02 (0.94–
1.10)
1.00 (0.97–
1.04)
Former smokers + pack-years 11–15 7,603 176
(2.3)
603 (7.9) 1,960
(25.8)
1,819
(23.9)
3,045
(40.0)
1.46 (1.01–
2.10)
1.27 (1.06–
1.71)
1.16 (1.12–
1.20)
0.94 (0.91–
0.97)
Current smokers + pack-years<5 1,213 57 (4.7) 140
(11.5)
414 (34.1) 274 (22.6) 328 (27.0) 3.34 (2.07–
5.22)
2.01 (1.52–
2.65)
1.61 (1.48–
1.76)
0.69 (0.59–
0.80)
Current smokers + pack-years 6–10 2,135 103
(4.8)
268
(12.6)
682 (31.9) 452 (21.2) 630 (29.5) 3.59 (3.08–
4.19)
2.31 (1.90–
2.80)
1.61 (1.45–
1.78)
0.81 (0.68–
0.95)
(Continued)
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adjusted for age at menarche and parity, the estimates for smoking status were attenuated
slightly (S1 Table).
Sensitivity analyses and meta-analyses
After excluding the UK Biobank data, the associations in former smokers with premature
(1.04, 0.86–1.26; p = 0.641) and early (1.01; 0.87–1.18; p = 0.730) menopause were no longer
significant (S2 Table). In addition, when intensity, duration, and age at start of smoking were
analysed by further adjusting for other smoking characteristics (S3 Table), a similar set of rela-
tionships were found as when the UK Biobank data were included, except that for current
smokers the risk of early menopause was no longer significant (1.28; 0.91–1.81; p = 0.061)
compared with the reference group (women who had quit smoking for at least 11 years). The
study-specific regressions and random-effects meta-analysis for the associations between each
level of cigarettes smoking exposures and each category of menopause showed consistent
results with the main analysis (S4 Table).
Table 3. (Continued)
N Age in years at menopause, n (%) Adjusted RRR (95% CI)�
<40 40–44 45–49 50–51 �52 <40 40–44 45–49 �52
Current smokers + pack-years 11–
15
2,765 157
(5.7)
440
(15.9)
1,008
(36.5)
570 (20.6) 590 (21.3) 4.35 (2.78–
5.92)
3.01 (2.15–
4.21)
1.90 (1.69–
2.14)
0.60 (0.51–
0.70)
Age started smoking, years
Never smoker 119,072 1,965
(1.7)
7,776
(6.5)
27,950
(23.5)
29,674
(24.9)
51,707
(43.4)
1.00 1.00 1.00 1.00
Former smokers + age started at
�20
11,593 184
(1.6)
812 (7.0) 2,958
(25.5)
2,883
(24.9)
4,756
(41.0)
1.01 (0.76–
1.35)
1.10 (0.90–
1.36)
1.09 (1.02–
1.18)
0.94 (0.86–
1.03)
Former smokers + age started at 16–
19
22,814 407
(1.8)
1,738
(7.6)
5,608
(24.6)
5,478
(24.0)
9,583
(42.0)
1.12 (0.95–
1.31)
1.20 (1.03–
1.39)
1.10 (1.03–
1.17)
0.98 (0.95–
1.00)
Former smokers + age started at
�15
8,740 215
(2.5)
781 (8.9) 2,426
(27.8)
2,035
(23.3)
3,283
(37.6)
1.48 (1.27–
1.71)
1.39 (1.22–
1.57)
1.28 (1.17–
1.40)
0.89 (0.86–
0.93)
Current smokers + age started at
�20
7,484 187
(2.5)
753
(10.1)
2,531
(33.8)
1,846
(24.7)
2,167
(29.0)
1.66 (1.33–
2.08)
1.65 (1.56–
1.75)
1.45 (1.38–
1.53)
0.70 (0.62–
0.79)
Current smokers + age started at
16–19
8,399 259
(3.1)
936
(11.1)
2,831
(33.7)
1,934
(23.0)
2,439
(29.0)
2.02 (1.74–
2.35)
1.85 (1.64–
2.08)
1.57 (1.45–
1.71)
0.72 (0.69–
0.76)
Current smokers + age started at
�15
4,665 210
(4.5)
616
(13.2)
1,644
(35.2)
974 (20.9) 1,221
(26.2)
2.92 (2.38–
3.60)
2.32 (2.01–
2.68)
1.81 (1.65–
1.98)
0.72 (0.66–
0.77)
Years since quitting smoking before
menopause, years
Never smoker 119,072 1,965
(1.7)
7,776
(6.5)
27,950
(23.5)
29,674
(24.9)
51,707
(43.4)
1.00 1.00 1.00 1.00
Current smoker 24,444 769
(3.1)
2,653
(10.9)
8,100
(33.1)
5,671
(23.2)
7,251
(29.7)
2.10 (1.79–
2.45)
1.82 (1.73–
1.92)
1.53 (1.46–
1.61)
0.73 (0.67–
0.78)
1–5 7,279 218
(3.0)
792
(10.9)
2,303
(31.6)
1,729
(23.8)
2,237
(30.7)
1.70 (1.56–
1.86)
1.70 (1.49–
1.93)
1.51 (1.39–
1.64)
0.82 (0.77–
0.87)
6–10 7,107 177
(2.5)
637 (8.9) 1,947
(27.4)
1,585
(22.3)
2,761
(38.9)
1.42 (1.05–
1.91)
1.52 (1.37–
1.69)
1.24 (1.16–
1.33)
0.87 (0.80–
0.94)
11–15 7,752 140
(1.8)
668 (8.6) 1,944
(25.3)
2,037
(26.2)
2,963
(38.1)
0.84 (0.74–
0.95)
1.25 (1.09–
1.42)
1.04 (0.98–
1.10)
0.81 (0.78–
0.85)
�Multinomial logistic regression model was used to estimate RRR and 95% CIs with the category of 50–51 years as reference. All RRRs were adjusted for race/ethnicity/
region, education level, and BMI.
Abbreviations: CI, confidence interval; cigs, cigarettes; RRR, relative risk ratio.
https://doi.org/10.1371/journal.pmed.1002704.t003
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Prospective associations
Overall, a similar pattern of results were obtained from prospective analyses that only included
women who experienced menopause after baseline. Due to the limited number of women
experiencing early menopause (<45 years) at a subsequent survey, some estimates of associa-
tion for early menopause were attenuated (e.g., cumulative dose of smoking in current smok-
ers) or with wide CIs (e.g., intensity of smoking in former smokers) (Table 4). The study-
specific regressions and random-effects meta-analysis for prospective analyses were provided
in S5 Table.
Fig 1. Relationship between smoking exposure and age at natural menopause. The cross-sectional associations of (A) intensity of smoking (cigarettes/day), (B)
cumulative dose of smoking (pack-years), (C) age started smoking (years), and (D) years since quitting smoking (years) with the risk for premature menopause (<40
years), early menopause (40–44 years), and menopause at 45–49 years in current and/or former smokers. All RRRs were adjusted for race/ethnicity/region, education level,
and BMI. Never smokers were used as reference group. RRR, relative risk ratio.
https://doi.org/10.1371/journal.pmed.1002704.g001
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Table 4. Prospective associations between cigarette smoking and age at menopause (n = 27,580).
N Age in years at menopause, n (%) Adjusted RRR (95% CI)�
<45 45–49 50–51 �52 <45 45–49 �52
Smoking status
Never smoker 14,401 209 (1.5) 2,535 (17.6) 3,695 (25.7) 7,962 (55.3) 1.00 1.00 1.00
Former smoker 8,337 163 (2.0) 1,714 (20.6) 2,170 (26.0) 4,290 (51.5) 1.21 (1.03–1.41) 1.11 (0.94–1.32) 0.94 (0.85–1.03)
Current smoker 4,842 141 (2.9) 1,425 (29.4) 1,257 (26.0) 2,019 (41.7) 1.67 (1.32–2.11) 1.55 (1.45–1.66) 0.78 (0.70–0.86)
Intensity of smoking, cigarettes/day
Never smoker 14,401 209 (1.5) 2,535 (17.6) 3,695 (25.7) 7,962 (55.3) 1.00 1.00 1.00
Former smokers + 1–9 cigs/day 1,819 27 (1.5) 335 (18.4) 487 (26.8) 970 (53.3) 1.01 (0.77–1.32) 1.01 (0.72–1.43) 0.93 (0.85–1.02)
Former smokers + 10–19 cigs/day 1,577 30 (1.9) 273 (17.3) 452 (28.7) 822 (52.1) 1.41 (0.74–2.71) 0.95 (0.69–1.31) 0.82 (0.69–0.96)
Former smokers + 20 or more cigs/day 1,445 40 (2.8) 323 (22.4) 384 (26.6) 698 (48.3) 1.99 (0.98–4.03) 1.24 (0.88–1.74) 0.85 (0.62–1.16)
Current smokers + 1–9 cigs/day 864 18 (2.1) 220 (25.5) 241 (27.9) 385 (44.6) 1.25 (0.76–2.05) 1.28 (1.05–1.57) 0.76 (0.69–0.85)
Current smokers + 10–19 cigs/day 1,553 56 (3.6) 485 (31.2) 397 (25.6) 615 (39.6) 2.11 (1.66–2.68) 1.68 (1.54–1.82) 0.74 (0.62–0.88)
Current smokers + 20 or more cigs/day 1,475 43 (2.9) 470 (31.9) 377 (25.6) 585 (39.7) 2.14 (1.60–2.88) 1.90 (1.49–2.43) 0.72 (0.65–0.80)
Duration of smoking before menopause,† years
Never smoker 14,401 209 (1.5) 2,535 (17.6) 3,695 (25.7) 7,962 (55.3) 1.00 1.00 1.00
Former smokers + duration <10 2,635 48 (1.8) 525 (19.9) 700 (26.6) 1,362 (51.7) 1.12 (0.68–1.84) 1.06 (0.91–1.23) 0.91 (0.82–1.02)
Former smokers + duration 10–20 1,337 25 (1.9) 302 (22.6) 348 (26.0) 662 (49.5) 1.17 (0.89–1.54) 1.15 (1.01–1.31) 0.89 (0.79–1.02)
Current smokers + duration <10 79 10 (12.7) 30 (38.0) 17 (21.5) 22 (27.8) 11.53 (6.01–22.18) 2.74 (1.83–4.12) 0.60 (0.40–0.90)
Current smokers + duration 10–20 260 31 (11.9) 112 (43.1) 48 (18.5) 69 (26.5) 11.54 (7.00–19.01) 3.36 (2.29–4.93) 0.68 (0.45–1.01)
Cumulative dose of smoking,‡ pack-years
Never smoker 14,401 209 (1.5) 2,535 (17.6) 3,695 (25.7) 7,962 (55.3) 1.00 1.00 1.00
Former smokers + pack-years�10 1,781 31 (1.7) 288 (16.2) 478 (26.8) 984 (55.2) 1.15 (0.90–1.47) 0.88 (0.69–1.12) 0.97 (0.87–1.08)
Former smokers + pack-years 11–15 2,026 45 (2.2) 490 (24.2) 543 (26.8) 948 (46.8) 1.28 (1.03–1.60) 1.16 (0.93–1.45) 0.83 (0.76–0.90)
Current smokers + pack-years�10 441 10 (2.3) 118 (26.8) 120 (27.2) 193 (43.8) 1.69 (1.00–2.88) 1.45 (0.97–2.18) 0.77 (0.65–0.90)
Current smokers + pack-years 11–15 771 27 (3.5) 234 (30.4) 193 (25.0) 317 (41.1) 2.29 (1.45–3.61) 1.70 (1.39–2.08) 0.77 (0.61–0.98)
Age started smoking, years
Never smoker 14,401 209 (1.5) 2,535 (17.6) 3,695 (25.7) 7,962 (55.3) 1.00 1.00 1.00
Former smokers + age started at �20 1,458 14 (1.0) 261 (17.9) 392 (26.9) 791 (54.3) 0.62 (0.38–1.03) 0.96 (0.78–1.17) 0.94 (0.83–1.07)
Former smokers + age started at 16–19 3,618 48 (1.3) 686 (19.0) 992 (27.4) 1,892 (52.3) 0.86 (0.66–1.11) 1.00 (0.81–1.24) 0.88 (0.80–0.97)
Former smokers + age started at �15 1,863 79 (4.2) 488 (26.2) 465 (25.0) 831 (44.6) 2.65 (2.00–3.52) 1.46 (1.03–2.07) 0.83 (0.76–0.92)
Current smokers + age started at�20 1,074 19 (1.8) 277 (25.8) 285 (26.5) 493 (45.9) 1.12 (0.55–2.28) 1.38 (1.15–1.66) 0.82 (0.70–0.95)
Current smokers + age started at 16–19 1,945 52 (2.7) 541 (27.8) 546 (28.1) 806 (41.4) 1.57 (1.17–2.09) 1.41 (1.28–1.56) 0.69 (0.63–0.77)
Current smokers + age started at�15 1,316 59 (4.5) 463 (35.2) 318 (24.2) 476 (36.2) 2.84 (2.35–3.42) 2.03 (1.85–2.24) 0.71 (0.57–0.88)
Years since quitting smoking before menopause§
Never smoker 14,401 209 (1.5) 2,535 (17.6) 3,695 (25.7) 7,962 (55.3) 1.00 1.00 1.00
Current smoker 4,210 133 (3.2) 1,275 (30.3) 1,109 (26.3) 1,693 (40.2) 1.97 (1.56–2.50) 1.63 (1.49–1.79) 0.72 (0.65–0.80)
1–5 692 20 (2.9) 190 (27.5) 166 (24.0) 316 (45.7) 1.70 (0.92–3.15) 1.52 (1.19–1.93) 0.90 (0.73–1.11)
6–15 1,179 33 (2.5) 318 (26.5) 268 (24.8) 560 (46.2) 1.52 (1.01–2.29) 1.40 (1.17–1.67) 0.88 (0.76–1.02)
15+ 4,425 33 (0.8) 678 (15.1) 1,202 (26.7) 2,512 (57.5) 0.86 (0.51–1.47) 1.00 (0.85–1.19) 0.74 (0.62–0.88)
�Multinomial logistic regression model was used to estimate RRR and 95% Cis, with the category of 50–51 years as reference. All RRRs were adjusted for race/ethnicity/
region, education level, and BMI.
†The categories of 10–14 years and 15–20 years were combined as 10–20 years for analysis for limited number of women with early menopause.
‡The categories of�5 pack-years and 6–10 pack-years were combined as�10 pack-years for analysis for limited number of women with early menopause.
§The categories of 6–10 and 11–15 were combined as 6–15 for analysis due to the insufficient number of women with early menopause.
Abbreviations: CI, confidence interval; cigs, cigarettes; RRR, relative risk ratio.
https://doi.org/10.1371/journal.pmed.1002704.t004
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Discussion
Summary of results
Our results indicate that compared with never smokers, both current smokers and former
smokers are at higher risk of premature and early menopause and menopause at 45–49 years,
although the association is weaker among former smokers. Intensity, duration, cumulative
dose, younger age at start smoking, and shorter time since quitting smoking are all associated
with earlier age at menopause in both current and former smokers, but the excess risks were
substantially lower in former smokers. Consistent dose-response relationships were observed
in both current and former smokers. Smoking duration is a much stronger predictor of earlier
menopause than others. Current smokers with long duration (15–20 years) showed particu-
larly higher risk of premature and early menopause. These findings highlight the clear benefits
of early smoking cessation to lower the excess risk of earlier menopause.
Former smokers and age at menopause
Current smoking is an established risk factor for earlier menopause [3,15,16], whereas the rela-
tionship between past smoking and age at menopause is less conclusive. Compared with never
smokers, some previous studies showed that former smokers had earlier menopause [20,25],
others found no association [26–28], and one study a reduced risk [29]. The number of former
smokers in studies that found no association was small (around 1,000 women) [26,28], and the
study that found a negative association had only 83 former smokers [29]. We found that being
a former smoker was significantly associated with premature and early menopause, as well as
menopause at 45–49 years, indicating that the effect of smoking on ovarian senescence is not
limited to current smoking.
Potential mechanisms linking smoking to earlier menopause
Several hypotheses might explain why smoking leads to earlier menopause. First, cigarette
smoke yields polycyclic aromatic hydrocarbons (PAHs), which activate the aromatic hydrocar-
bon receptor. This receptor induces expression of the apoptosis-promoting gene Bcl2-asso-
ciated X protein (BAX) in oocytes, which increases the rate of oocyte apoptosis leading to
earlier ovarian failure [30]. This mechanism indicates a permanent, irreversible influence that
occurs in both former and current smokers and may explain why former smokers have an ear-
lier menopause than never smokers. PAHs also induce other hepatic enzymes, such as mono-
oxygenases and transferases, which enhance steroid metabolism and clearance [31].
Furthermore, PAHs induce or up-regulate the expression of cytochrome P450 enzymes to sol-
ubilize and decrease the serum estrogen levels [32]. Second, smoking has been suggested to
have an anti-estrogenic effect [33]; awaking the 2-hydroxylation pathway in the liver would
convert bioactive estrogens into 2-hydroxyestrogens with minimal activity in peripheral tissues
[34]. Finally, smoking increases adrenal production of androgens, which resists or blunts the
functions of estrogens [35]. The latter two mechanisms reflect a temporary and reversible
effect and may explain why being a current smoker has a greater impact on earlier menopause
than being a former smoker.
Intensity, duration, quantity, and timing of smoking and age at menopause
Some studies have reported a potential dose-response relationship between intensity of smok-
ing and earlier menopause [17,18,28], while other studies have shown no such association
[27,29]. A systematic review including virtually every informative study indicated that the
dose-response gradient was slight and nonlinear [16]. However, limited by the significant
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heterogeneity between studies, this review neither gave overall estimates nor did it separate the
estimates for current and former smokers. In contrast, we observed a clear dose-response rela-
tionship in both current and former smokers, compatible with the toxic effect of smoking on
oocyte quantity. Experimental studies using animal models have shown that exposure to
tobacco smoke causes follicle loss at all stages of folliculogenesis [36], and a dose-response
trend exists for nicotine on impairment in follicle growth [37].
Evidence of the association between duration of smoking and age at menopause has been
inconsistent [17,18,26]. A recent large-scale study reported a possible dose-response relation-
ship between smoking duration and earlier menopause [18]. However, the analyses were per-
formed in all smokers, and thus the specific associations of smoking duration among former
or current smokers could not be examined. By definition, smoking duration is somewhat con-
founded with former/current smoking status, warranting separate analysis. Also, in that study
[18], because age at menopause was categorized only into two categories of<50 and�50, the
association with premature or early menopause could not be examined. We found that pro-
longed smoking was linked to earlier menopause, both in former and current smokers. The
associations of smoking duration with premature and early menopause were much higher in
current smokers than that in former smokers. The lowest BIC value indicates that duration of
smoking is the strongest predictor of earlier age at menopause in this study.
Number of pack-years reflects a person’s cumulative cigarette exposure over time. Of the
four cross-sectional studies that examined the association between pack-years and age at men-
opause [17,18,30,38], three suggested a slight dose-response relationship [17,18,38], with a
higher number of pack-years associated with earlier menopause. However, all three studies
used data from all smokers without stratifying by current or former smoking status. Our
results showed that higher cumulative dose of smoking was strongly associated with earlier
menopause in both current and former smokers.
Some studies found a dose-response relationship with younger age at starting to smoke and
earlier age at menopause [17,18], while others did not detect a significant association [20,39].
We found that the earlier age at starting to smoke, the higher the risk of experiencing earlier
menopause both among current and former smokers, especially for women who started smok-
ing before age 15. Similar to one previous study [20], we found that the more recently women
had quit smoking, the higher the risk of earlier menopause. This finding indicated that the
residual influence of smoking on earlier menopause declined as years since quitting smoking
increased.
Limitations
Some limitations need to be considered when interpreting these results. Current smoking sta-
tus was determined at the baseline survey. For women who experienced menopause after base-
line, their smoking status was measured at varying years before menopause. Thus, the
possibility of measurement errors in smoking status may have arisen. Smoking, however, is a
habit that is resistant to change. In studies including women who reported smoking status
both before and after menopause (e.g., UK Biobank, NSHD, NCDS, SWAN, and SABRE), the
concordance was over 83%, supporting the use of smoking exposure at baseline as a proxy for
smoking status close to or after menopause. For example, when van Asselt and colleagues [26]
repeated their analyses by defining current and former smokers at 5 years before menopause
instead of 1 year, the estimated effects were similar. This suggests that among women with
menopause after baseline in this study (the mean baseline age and menopausal age for these
women were 46.0 and 51.5 years, respectively), our estimates reflect the effect of smoking
exposure just before or close to menopausal age. Another limitation was that the influence of
Relationship between smoking and age at menopause
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002704 November 27, 2018 14 / 19
passive smoking, which may lead to earlier menopause [18], was not considered in this study;
thus, when the never-smoking group was used as the reference without excluding passive
smokers, the association might have been underestimated. However, SWAN study found that
both baseline and time-varying passive smoking did not predict age at menopause [3], so we
assume that the bias from not including passive smoking is small. Third, age at menopause
was self-reported. However, because premature and early menopause are landmark health
events, we consider major misclassification unlikely. Fourth, the original questions used to col-
lect smoking data may not be exactly the same across studies, which may lead to some hetero-
geneity in the responses. Based on validation studies, smoking questions that have a
reasonably standard format (e.g., questions about smoking status or duration of smoking) are
not expected to impact the findings in any substantive way [40,41]. Finally, over 80% women
are white in our study, which may limit the generalizability of the findings to other races.
Strengths of this study
The main strength of this study was the use of pooled individual-level data from 17 studies
across different geographic regions and populations, which resulted in sufficient statistical
power to perform both cross-sectional and prospective analyses in current and former smokers
separately. The percentages of women with missing data on smoking status, BMI, education
level, and race/ethnicity were relatively small (ranging from 1.3% to 5.4%). To our knowledge,
it is the first study of this size to examine and quantify the dose-response relationships between
intensity, duration, cumulative dose, timing of smoking, and age at menopause separately for
former and current smokers. Also, the participant-level data in InterLACE enabled harmoniz-
ing variables using common definitions, coding and cut points, which is not usually possible
with meta-analyses of published results.
Conclusion
Our pooled analysis provides robust evidence that both former and current smokers are at an
increased risk of experiencing earlier menopause, but the risk is considerably lower for former
smokers. We found significant relationships between the intensity, duration, cumulative dose,
the timing of starting, and years since quitting smoking with the risk of earlier menopause in
both current and former smokers. Duration and cumulative dose of smoking are good predic-
tors of age at menopause. Current smokers with 15 or more years of smoking duration experi-
ence a 15-fold increased risk of premature and a 6-fold increased risk of early menopause.
Given that 175 million women ages 15 or older are current smokers globally [42], our findings
highlight the clear benefits for women of early smoking cessation to lower their excess risk of
earlier menopause, thereby reducing the increased risks of chronic diseases (e.g., cardiovascu-
lar disease and osteoporosis) associated with both smoking and earlier menopause. Further-
more, smoking cessation itself reduces the risk of many other smoking-related diseases, such
as lung cancer and chronic obstructive pulmonary disease. In our future research, we intend to
quantify the direct and indirect effects (via age at menopause) of smoking on the risk of
chronic diseases.
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